daw1 Antibody

What is DAW1 and what cellular functions does it serve?

DAW1 (Dynein Assembly Factor with WD Repeat Domains 1) is a protein-coding gene also known as ODA16, WDR69, or FLJ25955. It plays a critical role in cilia motility by enhancing the delivery of dynein complexes to axonemal microtubules .

DAW1 contains eight WD repeat domains that form a beta-propeller structure. In humans, the DAW1 protein shares approximately 58% sequence identity with its ortholog in the green algae Chlamydomonas reinhardtii (called ODA16), indicating high evolutionary conservation of this protein family . The highly conserved nature of this protein across species underscores its functional importance.

DAW1 functions primarily in motile ciliated tissues. Studies in multiple organisms have demonstrated that DAW1 is essential for:

• Left-right organ asymmetry determination during development

• Proper ciliary beating in respiratory epithelium

• Normal motility of sperm in reproductive systems

• Fluid flow in excretory systems (e.g., planarian protonephridia)

What tissues commonly express DAW1 protein?

DAW1 expression follows a specific pattern consistent with its function in motile cilia:

The expression pattern is consistent with organs and tissues containing motile cilia, which aligns with DAW1's functional role in ciliary motility .

What are the best applications for DAW1 antibodies in research?

Based on the search results, DAW1 antibodies have demonstrated utility in several key experimental techniques:

• Immunohistochemistry (IHC): For visualization of DAW1 in tissue sections (dilution 1:200-1:500)

• Western Blot (WB): For detection of DAW1 protein in cell or tissue lysates

• Immunocytochemistry/Immunofluorescence (ICC/IF): For subcellular localization studies

Multiple validated antibodies are available from different sources with verified applications:

Most DAW1 antibodies are polyclonal and raised in rabbits, targeting specific amino acid regions of the human DAW1 protein .

How can I validate the specificity of a DAW1 antibody?

Validating antibody specificity is crucial for reliable research results. For DAW1 antibodies, consider implementing these methodological approaches:

• Genetic knockdown/knockout controls:

  • Compare antibody staining between wild-type and DAW1 knockdown/knockout samples

  • RNA interference (RNAi) in model organisms like planarians has been successfully used to validate DAW1 antibodies

• Recombinant protein controls:

  • Use recombinant DAW1 protein fragments as positive controls

  • Some commercial antibodies are tested against protein arrays of 364 human recombinant protein fragments

• Immunoblotting profile:

  • Verify that the antibody detects a band of the expected molecular weight (DAW1 should be approximately 55 kDa)

  • Compare expression across known DAW1-expressing and non-expressing tissues

• Multiple antibody approach:

  • Use antibodies targeting different epitopes of DAW1 to confirm consistent staining patterns

  • Compare results from monoclonal and polyclonal antibodies when available

• Subcellular localization:

  • Confirm DAW1 localization is consistent with its known distribution near basal bodies and ciliary structures

What are the known DAW1 mutations and how might they affect antibody recognition?

Several pathogenic DAW1 variants have been identified in ciliopathy patients:

These mutations may affect antibody recognition depending on the epitope targeted by the antibody. Considerations for researchers:

• Antibodies targeting regions after truncation mutations (p.Trp119* or p.Leu66*) would not detect the truncated protein

• Missense mutations may alter protein conformation and potentially affect epitope accessibility

• Protein stability is reduced with pathogenic missense variants, potentially reducing signal intensity

When using DAW1 antibodies in ciliopathy research, researchers should be aware of these variants and how they might affect antibody binding and experimental outcomes.

What protocols optimize DAW1 detection in immunofluorescence studies?

Based on published methodologies, the following protocol has been effective for DAW1 detection by immunofluorescence:

Sample Preparation:

• Fix cells with 4% paraformaldehyde for 15-60 minutes at room temperature

• Permeabilize with 0.1-0.25% Triton X-100 for 10 minutes

• Block with 2-5% BSA for 1 hour at room temperature

Immunostaining:

• Primary antibody incubation:

  • Use anti-DAW1 antibody at 1-3 μg/mL in 0.1-1% BSA

  • Incubate for 3 hours at room temperature or overnight at 4°C

• Secondary antibody incubation:

  • Use species-appropriate fluorophore-conjugated secondary antibody (e.g., Alexa Fluor 488 Rabbit Anti-Mouse IgG)

  • Dilute 1:400 and incubate for 30-45 minutes at room temperature

• Counterstain nuclei with DAPI

• For ciliary co-localization studies, consider co-staining with acetylated α-tubulin (e.g., using antibody clone 6-11B-1) to mark ciliary axonemes

Imaging Recommendations:

• Use confocal microscopy to precisely localize DAW1 relative to ciliary structures

• Include z-stack acquisition to visualize the full ciliary structure

• Use a minimum 20X magnification for adequate resolution of ciliary structures

How can I optimize DAW1 detection in Western blotting experiments?

For optimal Western blot detection of DAW1 protein, follow this methodological approach:

Sample Preparation:

• When analyzing DAW1 expression, consider treating cells with sodium butyrate (5 mM for 12-24 hours), which can enhance detection as demonstrated with tubulin acetylation

• Load 20-30 μg of total protein per lane

• Use appropriate positive controls (e.g., HeLa cells, which express detectable levels of DAW1)

Electrophoresis and Transfer:

• Use 4-12% Bis-Tris gradient gels for optimal separation

• Transfer to nitrocellulose membrane using standard protocols

Immunodetection:

• Block membrane with 5% skim milk for 1 hour at room temperature

• Incubate with anti-DAW1 primary antibody at 1-3 μg/mL in 2.5% skim milk overnight at 4°C on a rocking platform

• Wash thoroughly with TBS-T

• Incubate with HRP-conjugated secondary antibody at 1:4000 dilution

• Detect using ECL Western Blotting Substrate

Expected Result:

• DAW1 should be detected at approximately 55 kDa

• Comparison of DAW1 detection across multiple cell lines shows variable expression levels

How does DAW1 function in ciliary development and disease?

DAW1 plays a crucial role in the development and function of motile cilia across multiple organisms:

Developmental Functions:

• In zebrafish, Daw1 facilitates the timely onset of cilia motility during development

• Daw1-deficient zebrafish show reduced cilia motility early in development, with motility gradually increasing to near wild-type levels later in development

• This delayed motility leads to abnormal body axis curves during early development, which self-correct when motility reaches normal levels

Disease Associations:

• Biallelic DAW1 variants cause a motile ciliopathy characterized by laterality defects and subtle ciliary beating abnormalities

• DAW1 mutations affect left-right patterning more severely than respiratory function or fertility

• At the molecular level, DAW1 loss of function is associated with distal type 2 outer dynein arm assembly defects

Molecular Mechanism:

• DAW1 enhances the delivery of dynein complexes to axonemal microtubules

• The β-propeller structure formed by WD repeats in DAW1 binds to outer dynein arms (ODAs)

• This binding facilitates the transport of ODAs into the cilium via intraflagellar transport

What are appropriate controls when using DAW1 antibodies in research?

Implementing proper controls is essential for generating reliable data with DAW1 antibodies:

Positive Controls:

• Tissues: Node cells (embryonic), respiratory epithelium, testis

• Cell lines: HeLa cells (especially when treated with sodium butyrate)

• Model organisms: Zebrafish Kupffer's vesicle cells, planarian epidermal cells

• Recombinant protein: Purified DAW1 protein or fragments containing the antibody epitope

Negative Controls:

• Primary antibody omission: Perform the staining protocol without the primary DAW1 antibody

• Non-expressing tissues: Use tissues known not to express DAW1 or with minimal ciliated cells

• Genetic models: DAW1 knockdown/knockout samples when available

• Pre-absorption control: Pre-incubate the antibody with excess antigen peptide before staining

Specificity Controls:

• Multiple antibodies: Compare staining patterns using antibodies targeting different DAW1 epitopes

• siRNA/shRNA knockdown: Reduced signal should correspond to reduced DAW1 expression

• Co-localization: DAW1 should co-localize with ciliary markers in appropriate tissues

Can DAW1 antibodies be used effectively in model organisms?

DAW1 is highly conserved across species, making cross-reactivity possible. Here's a methodological assessment of DAW1 antibody use in model organisms:

Zebrafish (Danio rerio):

• DAW1 is 58% identical to human DAW1

• Zebrafish Daw1 plays crucial roles in cilia motility and left-right patterning

• Antibodies against human DAW1 may require validation for cross-reactivity, but structural conservation suggests potential utility

Planarians (Schmidtea mediterranea):

• Smed-DAW1 is 58% identical to human DAW1

• Expressed in epidermis, protonephridial system, and testes

• Human DAW1 antibodies have been successfully used in planarian research

Mouse (Mus musculus):

• High sequence homology to human DAW1

• Expressed in node cells during embryonic development

• Commercial antibodies may cross-react due to conservation

Chlamydomonas (Chlamydomonas reinhardtii):

• The founding member of this protein family (ODA16) shares 55% identity with human DAW1

• A useful model for studying fundamental cilia biology

• Antibodies developed against specific regions with high conservation may cross-react

When using human DAW1 antibodies in model organisms, researchers should:

• Validate cross-reactivity by Western blot

• Include appropriate genetic controls (e.g., knockdown/knockout)

• Consider epitope conservation when selecting an antibody

• Optimize immunostaining protocols for each model organism

How does DAW1 protein expression change during development?

DAW1 expression shows specific temporal patterns during development:

Early Embryonic Development:

• In mice, Daw1 expression is limited to distal, motile ciliated cells of the node, consistent with its role in left-right patterning

• In zebrafish, Daw1 is expressed in Kupffer's vesicle (equivalent to mouse node) during early somitogenesis stages

Developmental Timing Effects:

• Daw1-deficient zebrafish show interesting temporal effects:

  • Reduced cilia motility in early development

  • Gradual increase to near wild-type motility levels later in development

  • This temporal pattern explains why laterality defects (established early) are more severe than respiratory or fertility issues (affected later)

Tissue-Specific Development:

• Northern blotting studies have shown that gene expression is predominantly found in morphologically differentiated neurologic cells

• Expression increases during differentiation of ciliated tissues

Researchers studying DAW1 during development should consider:

• The specific developmental stages of their model organism

• The temporal window when DAW1 function is most critical

• The tissue-specific expression patterns relevant to their study

What methodological approaches can detect DAW1 in challenging samples?

When working with challenging samples or low DAW1 expression levels, consider these methodological approaches:

For Tissues with Low DAW1 Expression:

• Signal Amplification Systems:

  • Tyramide signal amplification (TSA) can enhance detection sensitivity

  • Quantum dot-based detection systems provide superior sensitivity and photostability

• Concentration Techniques:

  • Immunoprecipitation followed by Western blotting

  • Enrichment of ciliated cell populations before analysis

For Fixed Tissue Samples:

• Optimized Antigen Retrieval:

  • Heat-induced epitope retrieval in citrate buffer (pH 6.0)

  • Enzymatic retrieval with proteinase K for heavily fixed samples

• Extended Antibody Incubation:

  • Increase primary antibody concentration (2-5 μg/mL)

  • Extend incubation time to 48 hours at 4°C

For Ciliopathy Disease Models:

• Comparative Approaches:

  • Always run wild-type controls alongside disease models

  • Use co-staining with another ciliary marker (e.g., acetylated tubulin) to normalize expression

• Detection Strategies:

  • For missense mutations: Focus on both quantity and localization

  • For truncating mutations: Use N-terminal targeting antibodies